Alvotech (ALVO) Cash from Investing Activities (2022 - 2026)

Alvotech (ALVO) posted Cash from Investing Activities of -$46.2 million for Q1 2026, down 193.0% on a QoQ basis from -$15.8 million in Q4 2025, and down 126.5% year-over-year from $174.3 million in Q1 2025.

Alvotech (ALVO) Cash from Investing Activities (2022 - 2026) Analysis & Trends

Alvotech's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$46.2 million for Q1 2026.

  • Quarterly Cash from Investing Activities fell 126.5% year-over-year to -$46.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$130.0 million (down 450.93% YoY) and the FY2025 annual result came in at -$104.2 million, down 452.34% from the prior year.
  • Cash from Investing Activities was -$46.2 million for Q1 2026 at Alvotech, down from -$15.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $22.8 million in Q3 2024 and bottomed at -$63.5 million in Q4 2022.
  • A 5-year average of -$22.5 million and a median of -$18.9 million in 2024 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2024 — Cash from Investing Activities jumped 74.92% — and 2025, when it slumped 486.06%.
  • Alvotech's Cash from Investing Activities stood at -$63.5 million in 2022, then grew by 27.07% to -$46.3 million in 2023, then surged by 59.28% to -$18.9 million in 2024, then climbed by 16.44% to -$15.8 million in 2025, then slumped by 193.0% to -$46.2 million in 2026.
  • Business Quant data shows ALVO's Cash from Investing Activities at -$46.2 million in Q1 2026, -$15.8 million in Q4 2025, and -$39.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -60.00 Mn
10 Alvotech 907.91 Mn 907.91 Mn 5.09 Mn -46.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -46.20 Mn
Mar 31, 2026 -46.20 Mn
Dec 31, 2025 -15.77 Mn
Dec 31, 2025 -15.77 Mn
Sep 30, 2025 -39.45 Mn
Sep 30, 2025 -39.45 Mn
Jun 30, 2025 -28.60 Mn
Jun 30, 2025 -28.60 Mn
Mar 31, 2025 -20.40 Mn
Mar 31, 2025 -20.40 Mn
Dec 31, 2024 -18.87 Mn
Dec 31, 2024 -18.87 Mn
Sep 30, 2024 22.75 Mn
Sep 30, 2024 22.75 Mn
Jun 30, 2024 -7.09 Mn
Jun 30, 2024 -7.09 Mn
Mar 31, 2024 -3.48 Mn
Mar 31, 2024 -3.48 Mn
Dec 31, 2023 -46.34 Mn
Dec 31, 2023 -46.34 Mn